a possible new approach to aids treatment has emerged from laboratory tests at st bartholomew's hospital london of a drug being developed to treat cancer scotia a uk pharmaceutical company said yesterday that its anti-cancer compound ef13 killed white blood cells infected with hiv the compound did not harm uninfected cells and made them more resistant to hiv infection the next stage will be to hold clinical trials for ef13 as an aids drug which could take several years to com-plete the drug is the lithium salt of a fatty acid extract from evening primrose oil it is believed to kill infected cells by generating lethal levels of free radicals markets page 40